dostarlimab
gsk
['dostarlimab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'rectal']
patients with locally advanced #rectalcancer and tumors with dmmr have shown a remarkable response to treatment with the pd-1 inhibitor dostarlimab. #asco22 #precisionmedicine #crcsm
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.